Measurement method for unbound bilirubin in blood sample

Patent metadata

Field	Value
Publication number	US-10513676-B2
Application number	US-201615563525-A
Country	US
Kind code	B2
Filing date	Mar 30, 2016
Priority date	Mar 30, 2015
Publication date	Dec 24, 2019
Grant date	Dec 24, 2019

Abstract

Provided is a measurement method whereby the amount of unbound bilirubin (UB) can be exactly reflected whether a specimen contains a large amount of conjugated bilirubin or not. The measurement method for UB according to the present invention comprises decomposition step (i), decomposition stopping step (ii), contact step (iii) and detection step (iv). In decomposition step (i), a blood sample containing unconjugated bilirubin (iD-Bil) and conjugated bilirubin (D-Bil) is subjected to an oxidative decomposition reaction of UB in iD-Bil and D-Bil. In decomposition stopping step (ii), the oxidative decomposition reaction is stopped to give a decomposition product of the sample. In contact step (iii), the decomposition product of the sample is contacted with UnaG that is capable of specifically binding to iD-Bil. Separately, an unreacted sample, which is the blood sample not subjected to decomposition step (i), is contacted with UnaG too. In detection step (iv), the fluorescence of UnaG is detected from the decomposition product of the sample and from the unreacted sample. Then, the amount of UB is derived from the difference between the detected values.

First claim

The invention claimed is:

1. A method of measuring unbound bilirubin in a blood sample, the method comprising:
a decomposition step (i) that comprises subjecting a blood sample containing unconjugated bilirubin and conjugated bilirubin to oxidative decomposition reaction in which unbound bilirubin of the unconjugated bilirubin and the conjugated bilirubin receive the oxidative decomposition reaction;
a decomposition termination step (ii) that comprises terminating the oxidative decomposition reaction to obtain a decomposed sample;
a contact step (iii) that comprises separately bringing the decomposed sample and a non-reacted sample into contact with a polypeptide, the non-reacted sample being a blood sample not subjected to the oxidative decomposition reaction, the polypeptide having an ability to specifically bind to unconjugated bilirubin and display fluorescence properties; and
a detection step (iv) that comprises detecting fluorescence attributable to the polypeptide in each of the decomposed sample and the non-reacted sample, and using a difference between the fluorescence attributable to the decomposed sample and the fluorescence attributable to the non-reacted sample to determine a level of the unbound bilirubin.

2. The method of measuring unbound bilirubin according to claim 1 , wherein the blood sample is derived from a preterm infant.

3. The method of measuring unbound bilirubin according to claim 1 , wherein the blood sample has a serum total bilirubin concentration of not lower than 8 mg/dL.

4. The method of measuring unbound bilirubin according to claim 1 , wherein the blood sample has a conjugated bilirubin concentration of not lower than 1 mg/dL.

5. The method of measuring unbound bilirubin according to claim 1 , wherein the termination of the oxidative decomposition reaction is carried out by addition of an antioxidant substance.

6. The method of measuring unbound bilirubin according to claim 5 , wherein the antioxidant substance is ascorbic acid.

7. The method of measuring unbound bilirubin according to claim 1 , wherein the termination of the oxidative decomposition reaction is carried out after a lapse of not shorter than 10 seconds and not longer than 60 seconds from the initiation of the oxidative decomposition reaction in decomposition step (i).

8. The method of measuring unbound bilirubin according to claim 1 , wherein the addition of the antioxidant substance is carried out so as to achieve a concentration of the antioxidant substance of not lower than 0.1 wt % in the reaction system in decomposition termination step (ii).

9. The method of measuring unbound bilirubin according to claim 8 , wherein in a case in which the antioxidant substance is ascorbic acid, the addition of the ascorbic acid is carried out so as to achieve a concentration of the ascorbic acid of not higher than 32 wt % in the reaction system in decomposition termination step (ii).

10. The method of measuring unbound bilirubin according to claim 9 , wherein the ascorbic acid is diluted so as to achieve a concentration of the ascorbic acid of not higher than 0.8 wt % in the reaction system in contact step (iii).

11. The method of measuring unbound bilirubin according to claim 1 , wherein a dilution factor of the blood sample in the reaction system in decomposition step (i) is not smaller than 5 and not greater than 120 in terms of serum.

12. The method of measuring unbound bilirubin according to claim 11 , wherein
in decomposition step (i)
the oxidative decomposition reaction proceeds based on hydrogen peroxide and peroxidase, the hydrogen peroxide is generated from glucose in the presence of glucose oxidase, and
the reaction system of the oxidative decomposition reaction contains the glucose oxidase and the peroxidase each in an amount of not lower than 0.0128 U and not higher than 0.256 U per 1 μL of serum.

13. The method of measuring unbound bilirubin according to claim 1 , wherein the blood sample is a whole blood sample.

14. The method of measuring unbound bilirubin according to claim 13 , wherein the level of the unbound bilirubin determined in detection step (iv) is obtained after hematocrit correction.

15. The method of measuring unbound bilirubin according to claim 6 , wherein the ascorbic acid is diluted so as to achieve a concentration of the ascorbic acid of not higher than 0.8 wt % in the reaction system in contact step (iii).

Assignees

• Univ Kobe Nat Univ Corp

Inventors

• IWATANI Sota
• Morioka Ichiro
• Nakamura Hajime
• Miyawaki Atsushi
• Kumagai Akiko

Classifications

• C12Q1/28

  involving peroxidase · CPC title

• C12M1/3476 Primary

  Fluorescence spectroscopy · CPC title

• C12Q1/005

  involving specific analytes or enzymes (including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence) · CPC title

• G01N33/72

  involving blood pigments, e.g. haemoglobin, bilirubin {or other porphyrins; involving occult blood} · CPC title

• C12Q1/26

  involving oxidoreductase · CPC title